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EVIDENCE BASED NEURO-ONCOLOGY
Role of surgery in brain metastases
Altaf Ali Laghari, Syed Ijlal Ahmed, Muhammad Shahzad Shamim

Abstract
Brain metastases remain the commonest type of brain
tumour, being four times more common than primary
brain tumours. Although surgical intervention may be
recommended for one of various reasons in the
management of these tumours, including but not limited
to conformation of diagnosis, relief of mass effect,
improvement of neurological status and prolongation of
survival, the guidelines for management of brain
metastases remain largely subjective and therefore
controversial. Herein the authors have attempted to
review some of the existing evidence on role of surgery in
the management of brain metastases and have presented
their selected guidelines for the readers.
Keywords: Brain metastasis, Microsurgery, Radiosurgery,
Whole brain radiotherapy.

Introduction
Treatment strategies for brain metastases depend on
several factors. Some patients may be candidates for
whole brain radiotherapy (WBRT), while others may
require surgical resection followed by WBRT or local
radiation therapy. Stereotactic radiosurgery (SRS) has
added another dimension to the management of these
lesions. Surgery has a definite role in management as in
select cases it provides or confirms diagnosis, relieves
intracranial mass effect, improves symptoms, and may
also improve survival, all with low morbidity and mortality
rates.1 It is generally agreed upon, that to benefit from
surgical intervention, a patient with brain metastases
must have reasonable medical fitness, with a systemic
disease process amenable to benefit from local central
nervous system (CNS) tumour control.2 The objective of
this review is to discuss the role of surgery in the
treatment of brain metastases. Although there is
substantial literature on this topic, the authors have
mentioned few key articles only.
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Table: Management recommendations for patients with brain metastases.
Consider systemic therapy when:
1. BM from highly chemotherapy-sensitive PT
2. BM found on screening MRI with planned systemic treatment
3. BM from PT with identified molecular alteration amenable to targeted therapy
4. Other therapeutic options have been exhausted and there is a reasonable drug
available
Consider WBRT when:
1. CNS and systemic POD, with few systemic treatment options and poor PS
2. Multiple (> 3-10)* BMs, especially if PT known to be radiotherapy sensitive
3. Large (> 4 cm) BM, not amenable to SRS
4. Postsurgical resection of a dominant BM with multiple (> 3-10)* remaining BMs
5. Salvage therapy for recurrent BM after SRS or WBRT failure
Consider SRS when:
1. OM (1-3) or multiple BMs,* especially if PT is known to be radiotherapy resistant
2. Postsurgical resection of a single BM, especially if > 3 cm and in the posterior fossa
3. Local relapse after surgical resection of a single BM
4. Salvage therapy for recurrent OM (1-3)* after WBRT
Consider surgical resection when:
1. Uncertain diagnosis of CNS lesion(s)
2. 1-2 BMs, especially when associated with extensive cerebral edema
3. Dominant BM in a critical location
No treatment is recommended when:
1. Systemic POD, with few treatment options and poor PS
Abbreviations: BM: brain metastases; MRI: magnetic resonance imaging; OM: oligometastases;
POD: progression of disease; PS: performance status; PT: primary tumor; SRS: stereotactic
radiosurgery; WBRT: whole-brain radiation therapy.

management of brain metastases, MacGee et al., reported
better quality of life and survival after surgical resection of
solitary or single lung metastasis.3 Patchell et al., in one of
the most cited papers on this topic, reported longer
median survival (40 vs. 15 weeks) after surgical resection
with radiation therapy (XRT) of single metastasis
compared to XRT alone.4 Similar results were also
reported by Sause et al, in a retrospective review with
longer survival in the patients having surgical resection
and XRT compared to XRT alone in solitary brain
metastasis.5 Swayaet al., in another landmark paper, also
concluded that surgery was superior to SRS in prolonging
life, with better local control of the disease.6 Muacevic et
al., in their retrospective review of management of solitary
metastasis of less than 3.5 cm diameter concluded that
result of surgery with WBRT is comparable to SRS in local
tumour control rate.7 Zacet et al, reported results of 20years experience of surgical management of brain

1300
metastases from melanoma and concluded that surgical
resection along with WBRT improved survival and quality
of life in these patients.8 However other authors such as
Neill et al.,9 have argued that for single brain metastasis of
different cancers like lung, genitourinary, gastrointestinal
and melanoma, surgical resection compared to SRS
followed by low dose WBRT, does not improve survival.
Yoo et al.10 report results of 'microscopic total resection'
compared with 'gross resection', describing 'total
resection' as extension of resection to a depth of 5-mm
after gross resection and confirming tumour free limits by
frozen section. This is only possible in non-eloquent areas.
They compared 43 patients with another group of 51
patients with eloquent-situated brain metastases who
underwent conventional gross-total resection. The twoyear recurrence rates were 63.2% and 29.1% favouring the
microscopic total resection group (p< 0.003) Shimony et
al.,11 in their recent article, have reported earlier
resolution of peri-tumoural oedema with surgery
compared to SRS, resulting in earlier improvement in
symptoms and reduction of steroid use Lin X et al.,12 have
published their recommendations on clinical decisionmaking in treatment of brain metastases. These
recommendations are based on an extensive literature
review and we find them well balanced (Table-1).
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meetings for combined decision-making in patients with
brain metastases.
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